Bicara Therapeutics Inc.
BCAX
34 insider filings · Latest: Jun 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Nov 24 9:10 PM | Hyep Ivan | Proposed Sale | 17,795 | $18.55 | $330.1K | — | View → |
| Nov 24, 2025 | Nov 24 9:09 PM | Raben David | Proposed Sale | 5,500 | $18.45 | $101.5K | — | View → |
| Nov 21, 2025 | Nov 21 9:33 PM | Hyep Ivan | Proposed Sale | 605 | $18.15 | $11.0K | — | View → |
| Nov 21, 2025 | Nov 21 9:32 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.05 | $225.6K | — | View → |
| Oct 16, 2025 | Oct 16 8:13 PM | Mazumdar Claire | Proposed Sale | 24,103 | $18.83 | $453.8K | — | View → |
| Oct 15, 2025 | Oct 15 8:20 PM | Cohlhepp Ryan | Proposed Sale | 12,500 | $18.13 | $226.6K | — | View → |
| Oct 15, 2025 | Oct 15 8:18 PM | Mazumdar Claire | Proposed Sale | 13,289 | $18.84 | $250.4K | — | View → |
| Oct 13, 2025 | Oct 14 1:05 PM | Mazumdar Claire | Proposed Sale | 11,445 | $18.92 | $216.5K | — | View → |
| Oct 9, 2025 | Oct 9 8:31 PM | Hyep Ivan | Proposed Sale | 6,415 | $17.89 | $114.8K | — | View → |
| Oct 9, 2025 | Oct 9 8:08 PM | Raben David | Proposed Sale | 22,000 | $18.45 | $405.9K | — | View → |
| Oct 8, 2025 | Oct 8 8:04 PM | Hyep Ivan | Proposed Sale | 5,627 | $18.17 | $102.2K | — | View → |
| Oct 7, 2025 | Oct 7 8:20 PM | Hyep Ivan | Proposed Sale | 18,244 | $18.00 | $328.4K | — | View → |
| Oct 7, 2025 | Oct 7 8:07 PM | Cohlhepp Ryan | Proposed Sale | 10,900 | $18.00 | $196.2K | — | View → |
| Oct 6, 2025 | Oct 6 8:36 PM | Cohlhepp Ryan | Proposed Sale | 39,600 | $18.06 | $715.0K | — | View → |
| Oct 6, 2025 | Oct 6 8:07 PM | Hyep Ivan | Proposed Sale | 6,514 | $17.04 | $111.0K | — | View → |
| Sep 29, 2025 | Sep 29 8:38 PM | LARA MEISNER | Proposed Sale | 33,807 | $11.71 | $395.9K | — | View → |
| Jun 16, 2025 | Jun 16 8:29 PM | LARA S. MEISNER | Proposed Sale | 31,658 | $10.84 | $343.2K | — | View → |
| Mar 14, 2025 | Mar 14 8:21 PM | LARA S. MEISNER | Proposed Sale | 79,146 | $13.35 | $1.1M | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 10 8:43 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 19,475 | $20.56 | 19,475(I) | View → |
| Jun 9, 2026 | Jun 10 8:35 PM | Christopher BowdenDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:34 PM | Kate HavilandDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:34 PM | Kiran Mazumdar-ShawDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:33 PM | Scott M. RobertsonDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:33 PM | Michael PowellDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| Jun 9, 2026 | Jun 10 8:32 PM | Jake SimsonDirector | Grant/Award | 19,475 | $20.56 | 19,475(D) | View → |
| May 21, 2026 | May 26 9:48 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 70,584(D) | View → |
| May 18, 2026 | May 20 8:07 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 15,000 | $3.79 | 146,107(D) | View → |
| May 15, 2026 | May 18 8:24 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 101,334(D) | View → |
| May 8, 2026 | May 12 8:04 PM | William SchelmanChief Medical Officer | Grant/Award | 85,000 | $22.58 | 85,000(D) | View → |
| Apr 27, 2026 | Apr 28 11:49 PM | David RabenChief Medical Officer | Option Exercise | 5,500 | $3.79 | 41,913(D) | View → |
| Apr 21, 2026 | Apr 22 8:53 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 39,744(D) | View → |
| Apr 20, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 15,000 | $3.79 | 161,107(D) | View → |
| Apr 16, 2026 | Apr 20 11:27 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 22,760 | $5.45 | 558,432(D) | View → |
| Apr 15, 2026 | Apr 17 8:55 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 8,000 | $3.79 | 109,334(D) | View → |
| Mar 25, 2026 | Mar 26 11:21 PM | David RabenChief Medical Officer | Option Exercise | 5,500 | $3.79 | 47,413(D) | View → |
| Mar 23, 2026 | Mar 24 11:45 PM | Ivan HyepChief Financial Officer | Option Exercise | 9,200 | $3.79 | 48,944(D) | View → |
| Mar 20, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 1,596 | $3.79 | 176,107(D) | View → |
| Mar 19, 2026 | Mar 20 9:02 PM | Claire MazumdarDirector, Chief Executive Officer | Option Exercise | 6,905 | $3.79 | 177,703(D) | View → |
Page 1 of 2
Next →